Benralizumab, CAS 1044511-01-4

Description: Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.

CAS Number: 1044511-01-4

References: Menzies-Gow A, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019 Sep 25;5(3). pii: 00009-2019.

• SKU: TGMT10497-25mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T10497-25mg
• Package Unit: 25 mg
• Quantity Unit: STK